Results 161 to 170 of about 11,291,129 (270)
What's liver got to do with it? Hepatic response and survival in AL amyloidosis. [PDF]
Zonder JA.
europepmc +1 more source
Unusual Lesions in a Long‐Term Dialysis Patient
Oral Diseases, EarlyView.
Domenico De Falco +2 more
wiley +1 more source
Abstract Anti‐B cell maturation antigen (BCMA) therapies, including antibody‐drug conjugates, chimeric antigen receptor T cells, and bispecific antibodies (bsAbs), have recently revolutionized the treatment landscape of multiple myeloma. This review outlines the biologic rationale for targeting BCMA and sheds light on the mechanism of action of bsAbs ...
Enrica Manzato +5 more
wiley +1 more source
When Hematologic Response Does Not Translate to Cardiac Recovery in AL Amyloidosis. [PDF]
Futela P +6 more
europepmc +1 more source
Epidemiology of Systemic Light-Chain (AL) Amyloidosis
Systemic light-chain (AL) amyloidosis is a challenging, complex and heterogeneous disease. AL amyloidosis is classified under the category of plasma cell neoplasms and other diseases with paraproteins in the fifth edition of the World Health Organization
Rafael Ríos-Tamayo
core +1 more source
Radical Resection of the Third Portion of the Duodenum for Secondary Aortoduodenal Fistula
Secondary aortoduodenal fistula most commonly involves the third portion of the duodenum and requires definitive management of both vascular and gastrointestinal components. We demonstrate a step‐by‐step technique for radical duodenal resection and reconstruction performed in structured collaboration with cardiovascular surgeons.
Koji Kubota +4 more
wiley +1 more source
Spontaneous Acute Left-Sided Abdominal Pain in a Patient With AL Amyloidosis. [PDF]
Malik SAR, Goel U, Valent J, Anwer F.
europepmc +1 more source
Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis
Although still rarely diagnosed, amyloid light chain (AL) amyloidosis is the most common form of systemic amyloidosis. It is characterized by misfolded monoclonal immunoglobulin light chain fragments that accumulate extracellularly as amyloid fibrils ...
Rosanna A. M. Ghinai; Shameem Mahmood; Pinias Mukonoweshuro; Sally Webber; Ashutosh D. Wechalekar; Sally E. Moore
core
Push–pull hypothesis of Alzheimer's disease
Abstract The “push–pull” hypothesis of Alzheimer's disease (AD) emerges from a careful examination of the key discoveries over the past 40 years. Specifically, amyloid beta (Aβ) plays a direct role impairing endolysosome activity in neurons and microglia, promoting the collapse of proteostasis, reducing tau degradation, and facilitating the cell‐to ...
Matthew Townsend
wiley +1 more source

